Lvm Capital Management LTD Propanc Biopharma, Inc. Transaction History

Lvm Capital Management LTD

  • $869 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 04, 2022
SELL
$0.02 - $0.04 $400 - $800
-20,005 Closed
0 $0
Q1 2021

Apr 06, 2021
BUY
$0.22 - $0.56 $4,401 - $11,202
20,005 New
20,005 $5,000

About Propanc Biopharma, Inc.

PPCB Quotes by TradingView
  • Ticker PPCB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 677,177,984
  • Description
  • Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically....
More about PPCB
Track This Portfolio

Track Lvm Capital Management LTD Portfolio

Follow Lvm Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvm Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lvm Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email